Lonza, a global manufacturing partner to the pharma, biotech and nutrition industries, will invest in expanding drug product manufacturing capabilities in Switzerland with an additional aseptic flexible filling line for clinical supply of drug product in Stein (CH).   The new line will support liquid and lyophilized vial filling and processing, cartridges and pre-filled syringes. The new filling line will allow Lonza to process various modalities, including monoclonal antibodies, bioconjugates...